Reckitt Benckiser Group (LON:RB) Stock Rating Reaffirmed by Barclays

Reckitt Benckiser Group (LON:RB)‘s stock had its “buy” rating reissued by research analysts at Barclays in a research note issued to investors on Tuesday, Borsen Zeitung reports. They presently have a GBX 9,400 ($122.83) price target on the stock. Barclays‘s price target points to a potential upside of 25.17% from the company’s previous close.

Several other brokerages have also recently issued reports on RB. Credit Suisse Group lifted their price objective on Reckitt Benckiser Group from GBX 7,000 ($91.47) to GBX 7,200 ($94.08) and gave the stock a “neutral” rating in a report on Tuesday, July 28th. Deutsche Bank reissued a “buy” rating and issued a GBX 8,150 ($106.49) price target on shares of Reckitt Benckiser Group in a report on Thursday, September 3rd. Societe Generale cut their price target on Reckitt Benckiser Group from GBX 5,400 ($70.56) to GBX 5,200 ($67.95) and set a “sell” rating for the company in a report on Thursday, June 4th. Morgan Stanley reissued a “buy” rating on shares of Reckitt Benckiser Group in a report on Wednesday, July 8th. Finally, JPMorgan Chase & Co. reissued a “buy” rating and issued a GBX 8,150 ($106.49) price target on shares of Reckitt Benckiser Group in a report on Friday, September 11th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and thirteen have issued a buy rating to the company. Reckitt Benckiser Group presently has an average rating of “Buy” and a consensus target price of GBX 7,605.56 ($99.38).

Shares of RB stock opened at GBX 7,510 ($98.13) on Tuesday. The stock has a fifty day moving average price of GBX 7,550.52 and a 200 day moving average price of GBX 6,923.12. The stock has a market cap of $53.42 billion and a PE ratio of -19.82. Reckitt Benckiser Group has a 1 year low of GBX 5,130 ($67.03) and a 1 year high of GBX 8,191.30 ($107.03). The company has a debt-to-equity ratio of 127.83, a quick ratio of 0.61 and a current ratio of 0.83.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

See Also: Trading Penny Stocks

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.